75N93025C00039
Definitive Contract
Overview
Government Description
IS TO DEVELOP PAN-INFLUENZA INHIBITORS TARGETING THE PA ENDONUCLEASE FROM THE VIRAL REPLICATION COMPLEX BY DEMONSTRATING PYRONARIDINE AS A VIABLE SINGLE DOSE TREATMENT FOR EBOLA INFECTION IN NON-HUMAN PRIMATES TO JUSTIFY FURTHER IN VIVO STUDIES FOR U
Awardee
Awarding / Funding Agency
Place of Performance
Raleigh, NC 27606 United States
Pricing
Fixed Price
Set Aside
Small Business Set Aside - Total (SBA)
Extent Competed
Full And Open Competition After Exclusion Of Sources
Research Type
Small Business Innovation Research Program (SBIR) Phase II
Est. Average FTE
9
Related Opportunity
PHS 20251
Collaborations Pharmaceuticals was awarded
Definitive Contract 75N93025C00039 (75N930-25-C-00039)
worth up to $1,999,195
by the National Institute of Allergy and Infectious Diseases
in September 2025.
The contract
has a duration of 1 year 3 months and
was awarded
with a Small Business Total set aside
with
NAICS 541714 and
PSC AN12
via direct negotiation acquisition procedures with 4 bids received.
Status
(Open)
Last Modified 9/29/25
Period of Performance
9/29/25
Start Date
12/29/26
Current End Date
12/29/26
Potential End Date
Obligations
$2.0M
Total Obligated
$2.0M
Current Award
$2.0M
Potential Award
Award Hierarchy
Definitive Contract
75N93025C00039
Subcontracts
Activity Timeline
People
Suggested agency contacts for 75N93025C00039
Competition
Number of Bidders
4
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
EFJCLL37KKH3
Awardee CAGE
7BGW7
Agency Detail
Awarding Office
75N930 NATIONAL INSTITUTES OF HEALTH NIAID
Funding Office
75N930
Created By
hhssujeong
Last Modified By
hhsireyes
Approved By
hhsireyes
Legislative
Legislative Mandates
None Applicable
Performance District
NC-02
Senators
Thom Tillis
Ted Budd
Ted Budd
Representative
Deborah Ross
Modified: 9/29/25